文献速递骨质疏松与代谢性骨病创伤骨科

髋部骨折高风险筛查未影响跌倒风险:SCOOP研究事后分析

Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study.
PubMed 文献 · Osteoporos Int · 2020-01-20

SCOOP研究事后分析纳入12483名70-85岁女性,随机分为对照组和筛查组,筛查组对高髋部骨折风险者推荐抗骨质疏松治疗。分析显示,基线FRAX髋部骨折概率较高与跌倒可能性增加相关,但两组间跌倒风险因素均衡且跌倒发生率无差异,筛查未降低跌倒风险。

要点

  • FRAX髋部骨折概率每增加1%,跌倒风险增加1-2%。
  • 筛查组与对照组跌倒风险因素均衡,跌倒发生率无差异。
  • 筛查降低髋部骨折风险的效应并非通过减少跌倒介导。

核心结论

  • 筛查高FRAX髋部骨折概率以降低髋部骨折风险的有效性并非由减少跌倒所介导。

研究设计与样本

  • SCOOP研究事后分析,纳入12483名70-85岁女性,个体随机分为对照组(n=6250)和筛查组(n=6233),筛查组对高髋部骨折风险者推荐抗骨质疏松治疗,对照组接受常规护理,跌倒通过自报问卷捕获。

主要发现

  • 发生一次或多次跌倒的女性基线年龄略大于未跌倒者(平均差异0.70岁,95%CI 0.55-0.85,p<0.001)。
  • 较高的FRAX 10年髋部骨折概率与跌倒可能性增加相关,髋部骨折概率每增加1%,跌倒风险增加1-2%。
  • 研究组间跌倒风险因素均衡,跌倒发生率无差异证据。
  • 基线FRAX髋部骨折概率与跌倒风险在研究组间无交互作用(p=0.18),与筛查对被告知高髋部骨折风险女性的跌倒无影响一致。

临床怎么用

  • 针对高髋部骨折风险女性的筛查项目,若旨在降低髋部骨折,不应预期通过减少跌倒来介导效果。
  • 临床中对于高FRAX髋部骨折概率患者,仍需独立评估和干预跌倒风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: A reduction in hip fracture incidence following population screening might reflect the effectiveness of anti-osteoporosis therapy, behaviour change to reduce falls, or both. This post hoc analysis demonstrates that identifying high hip fracture risk by FRAX was not associated with any alteration in falls risk. INTRODUCTION: To investigate whether effectiveness of an osteoporosis screening programme to reduce hip fractures was mediated by modification of falls risk in the screening arm. METHODS: The SCOOP study recruited 12,483 women aged 70-85 years, individually randomised to a control (n = 6250) or screening (n = 6233) arm; in the latter, osteoporosis treatment was recommended to women at high risk of hip fracture, while the control arm received usual care. Falls were captured by self-reported questionnaire. We determined the influence of baseline risk factors on future falls, and then examined for differences in falls risk between the randomisation groups, particularly in those at high fracture risk. RESULTS: Women sustaining one or more falls were slightly older at baseline than those remaining falls free during follow-up (mean difference 0.70 years, 95%CI 0.55-0.85, p < 0.001). A higher FRAX 10-year probability of hip fracture was associated with increased likelihood of falling, with fall risk increasing by 1-2% for every 1% increase in hip fracture probability. However, falls risk factors were well balanced between the study arms and, importantly, there was no evidence of a difference in falls occurrence. In particular, there was no evidence of interaction (p = 0.18) between baseline FRAX hip fracture probabilities and falls risk in the two arms, consistent with no impact of screening on falls in women informed to be at high risk of hip fracture. CONCLUSION: Effectiveness of screening for high FRAX hip fracture probability to reduce hip fracture risk was not mediated by a reduction in falls.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Condurache CI, Chiu S, Chotiyarnwong P, et al. Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study. Osteoporos Int. 2020. PMID: 31960099. doi:10.1007/s00198-019-05270-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。